Stock VTR VENTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ventas, Inc.

Equities

VTR

US92276F1003

Specialized REITs

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
50.26 USD +2.57% Intraday chart for Ventas, Inc. +5.81% +0.84%
May. 30 Wells Fargo Adjusts Price Target on Ventas to $49 From $46 MT
May. 29 JPMorgan Adjusts Price Target on Ventas to $50 From $48 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 21,522 18,369 20,406 18,007 20,041 20,307 - -
Enterprise Value (EV) 1 33,574 29,813 32,284 30,182 33,023 33,194 33,313 33,272
P/E ratio 49.4 x 41.9 x 393 x -375 x -498 x 2,587 x 197 x 85.1 x
Yield 5.49% 4.37% 3.52% 4% 3.61% 3.62% 3.8% 4.15%
Capitalization / Revenue 5.56 x 4.84 x 5.33 x 4.36 x 4.46 x 4.21 x 3.97 x 3.83 x
EV / Revenue 8.67 x 7.86 x 8.43 x 7.31 x 7.34 x 6.88 x 6.51 x 6.28 x
EV / EBITDA 17.2 x 16.1 x 19.5 x 17.3 x 18 x 17.5 x 16.2 x 15.1 x
EV / FCF 38.3 x - - - - 49.4 x 39.6 x 36 x
FCF Yield 2.61% - - - - 2.02% 2.53% 2.78%
Price to Book 2.02 x 1.8 x 1.88 x 1.77 x 2.13 x 2.36 x 2.61 x 2.89 x
Nbr of stocks (in thousands) 372,736 374,571 399,176 399,718 402,104 404,049 - -
Reference price 2 57.74 49.04 51.12 45.05 49.84 50.26 50.26 50.26
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,873 3,795 3,828 4,129 4,498 4,826 5,115 5,302
EBITDA 1 1,955 1,856 1,656 1,744 1,834 1,899 2,053 2,206
EBIT 1 909.8 746.7 459 545.7 441.6 644.8 705.2 918.5
Operating Margin 23.49% 19.67% 11.99% 13.22% 9.82% 13.36% 13.79% 17.32%
Earnings before Tax (EBT) 1 359.4 344.7 61.39 -64.37 -50.51 46.31 161.6 295.2
Net income 1 433 439.1 49.01 -47.45 -40.97 -6.422 57.82 107.1
Net margin 11.18% 11.57% 1.28% -1.15% -0.91% -0.13% 1.13% 2.02%
EPS 2 1.170 1.170 0.1300 -0.1200 -0.1000 0.0194 0.2553 0.5905
Free Cash Flow 1 877.1 - - - - 672 842.1 925.4
FCF margin 22.65% - - - - 13.92% 16.46% 17.45%
FCF Conversion (EBITDA) 44.86% - - - - 35.39% 41.01% 41.96%
FCF Conversion (Net income) 202.56% - - - - - 1,456.47% 863.88%
Dividend per Share 2 3.170 2.142 1.800 1.800 1.800 1.821 1.908 2.086
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,022 1,018 1,023 1,037 1,051 1,077 1,106 1,150 1,164 1,200 1,191 1,211 1,224 1,252 1,260
EBITDA 1 405.3 431.2 416.4 438.4 441.4 432.2 459.8 469.9 472.1 477.1 477 486.6 491.9 495 515.8
EBIT 1 86.36 142.2 133.3 136.9 117.2 150.1 155.2 99.51 36.82 176.8 142.2 141.5 140.9 146.2 -
Operating Margin 8.45% 13.97% 13.03% 13.2% 11.15% 13.93% 14.02% 8.65% 3.16% 14.74% 11.94% 11.69% 11.51% 11.68% -
Earnings before Tax (EBT) 1 - - - - - - - - - -15.54 22.38 14 17.43 21.51 44.2
Net income 1 -40.85 38.73 -42.42 1.256 -45.02 17.52 103.5 -71.12 -90.82 -14.31 5.692 2.227 -2.684 -10.93 7.331
Net margin -4% 3.81% -4.15% 0.12% -4.28% 1.63% 9.35% -6.19% -7.8% -1.19% 0.48% 0.18% -0.22% -0.87% 0.58%
EPS 2 -0.1000 0.1000 -0.1100 - -0.1100 0.0400 0.2600 -0.1800 -0.2300 -0.0400 0.008250 0.0233 0.0219 0.0157 0.0708
Dividend per Share 2 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4564 0.4596 0.4611 0.4835 0.5036
Announcement Date 2/17/22 5/5/22 8/4/22 11/3/22 2/9/23 5/8/23 8/3/23 11/2/23 2/14/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,052 11,444 11,878 12,174 12,982 12,886 13,006 12,965
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 6.164 x 6.164 x 7.171 x 6.983 x 7.078 x 6.787 x 6.334 x 5.878 x
Free Cash Flow 1 877 - - - - 672 842 925
ROE (net income / shareholders' equity) 4.19% 4.26% 0.47% -0.45% -0.42% 0.42% 1.51% 3.01%
ROA (Net income/ Total Assets) 1.83% 1.81% 0.2% -0.19% -0.17% 0.1% 0.56% 1.08%
Assets 1 23,638 24,311 24,324 24,457 24,102 -6,530 10,387 9,916
Book Value Per Share 2 28.50 27.20 27.20 25.40 23.40 21.30 19.20 17.40
Cash Flow per Share 2 3.890 3.850 2.660 2.780 2.760 3.080 3.400 3.730
Capex 1 561 529 433 454 643 211,884 234,561 -
Capex / Sales 14.48% 13.93% 11.31% 11% 14.3% 4,390.19% 4,585.9% -
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Ventas, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
50.26 USD
Average target price
53.5 USD
Spread / Average Target
+6.45%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

1st Jan change Capi.
VENTAS, INC. Stock Ventas, Inc.
+0.84% 20.31B
WELLTOWER INC. Stock Welltower Inc.
+14.97% 61.99B
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
+0.51% 14.01B
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+5.45% 7.99B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-5.80% 6.14B
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+14.32% 3.63B
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
+2.24% 3.38B
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
+9.16% 3.22B
AEDIFICA SA Stock Aedifica SA
-6.13% 3.08B
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+18.32% 2.87B
Healthcare REITs
  1. Stock Market
  2. Equities
  3. VTR Stock
  4. Financials Ventas, Inc.